ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy

BACKGROUND: Polymorphisms in the excision repair cross-complimentary group 1 (ERCC1) gene have been involved in the prognosis of various cancers. In the present study, we evaluated the prognostic role of the two most common ERCC1 polymorphisms in patients with T4 breast cancer receiving platinum-bas...

詳細記述

保存先:
書誌詳細
主要な著者: Palomba, Grazia, Atzori, Francesco, Budroni, Mario, Ombra, MariaNeve, Cossu, Antonio, Sini, MariaCristina, Pusceddu, Valeria, Massidda, Bruno, Frau, Barbara, Notari, Francesca, Ionta, MariaTeresa, Palmieri, Giuseppe
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2014
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4177579/
https://ncbi.nlm.nih.gov/pubmed/25253066
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-014-0272-4
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料